5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler

DEVICE2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

CompletedNCT00239473

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2002-11-30Target: 429Updated: 2013-11-01

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

CompletedNCT00240435

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2002-11-30Target: 491Updated: 2013-11-01